{
    "ucits": true,
    "type": "ETF",
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Derivatives, Synthetic replication, Structured product features, Exposure to futures contracts, Compounding effect, High risk profile",
    "classification": "complex",
    "supporting_data": "The product is a WisdomTree BTP 10Y 3x Daily Leveraged Exchange Traded Product (ETP) that is UCITS eligible but provides 3 times leveraged exposure to BTP futures contracts, indicating significant leverage beyond typical UCITS limits. It uses derivatives (futures contracts) as an integral part of its investment objective to achieve leveraged exposure, which introduces counterparty and market risks that are complex for retail investors to understand. The replication method is synthetic, relying on futures rather than physical holdings, adding opacity and complexity. The product has a daily reset of leverage, causing a compounding effect that makes returns over periods longer than one day deviate from simple multiples of the index, increasing complexity. The risk indicator is at the highest level (7/7), reflecting very high risk. The product documentation explicitly states it is 'not simple and may be difficult to understand,' confirming its complex nature. According to MiFID II Article 254, Delegated Regulation EU 2017/565 Article 57, and ESMA guidelines, such featuresu2014significant leverage, use of derivatives integral to strategy, synthetic replication, and complex payoff structuresu2014classify the product as complex. UCITS ETFs are generally presumed non-complex, but this presumption is overturned here due to the leveraged synthetic exposure and derivative use. Therefore, an appropriateness assessment is required before sale to retail investors under MiFID II rules."
}